Related references
Note: Only part of the references are listed.RNA N6-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m6A-GLUT1-mTORC1 Axis and Is a Therapeutic Target
Huarong Chen et al.
GASTROENTEROLOGY (2021)
METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST
Xiao Yang et al.
MOLECULAR CANCER (2020)
m6A-dependent glycolysis enhances colorectal cancer progression
Chaoqin Shen et al.
MOLECULAR CANCER (2020)
m(6)A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation
Jihao Xu et al.
ONCOLOGY REPORTS (2020)
FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair
Prabhu Mathiyalagan et al.
CIRCULATION (2019)
Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes
Ying Yang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
The Critical Role of RNA m6A Methylation in Cancer
Qing Lan et al.
CANCER RESEARCH (2019)
Importance of m N6-methyladenosine (m6A) RNA modification in cancer
Gulten Tuncel et al.
MEDICAL ONCOLOGY (2019)
N6-Methyladenosine and Viral Infection
Wei Dang et al.
FRONTIERS IN MICROBIOLOGY (2019)
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
Ting Li et al.
MOLECULAR CANCER (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
The emerging role of mRNA methylation in normal and pathological behavior
M. Engel et al.
GENES BRAIN AND BEHAVIOR (2018)
Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
A. Visvanathan et al.
ONCOGENE (2018)
HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g
Xiaoli Cai et al.
CANCER LETTERS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition
Wenfeng Hua et al.
GYNECOLOGIC ONCOLOGY (2018)
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer
Jun Liu et al.
NATURE CELL BIOLOGY (2018)
RNA m6A modification and its function in diseases
Jiyu Tong et al.
FRONTIERS OF MEDICINE (2018)
Inhibition of cell-adhesion protein DPYSL3 promotes metastasis of lung cancer
Yang Yang et al.
RESPIRATORY RESEARCH (2018)
METTL14 Suppresses the Metastatic Potential of Hepatocellular Carcinoma by Modulating N6-Methyladenosine- Dependent Primary MicroRNA Processing
Jin-Zhao Ma et al.
HEPATOLOGY (2017)
Post-transcriptional gene regulation by mRNA modifications
Boxuan Simen Zhao et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Exclusion of Kaposi Sarcoma From Analysis of Cancer Burden Reply
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program
Sicong Zhang et al.
CANCER CELL (2017)
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase
Zejuan Li et al.
CANCER CELL (2017)
Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology
Mireia Casasampere et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2016)
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
Chuanzhao Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
Jane Antony et al.
SCIENCE SIGNALING (2016)
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
Jane Antony et al.
SCIENCE SIGNALING (2016)
Colorectal cancer statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
The dynamic epitranscriptome: N6-methyladenosine and gene expression control
Kate D. Meyer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Current status of screening for colorectal cancer
K. Garborg et al.
ANNALS OF ONCOLOGY (2013)
Dihydroceramide desaturase and dihydrosphingolipids: Debutant players in the sphingolipid arena
Gemma Fabrias et al.
PROGRESS IN LIPID RESEARCH (2012)
Annual Report to the Nation on the Status of Cancer, 1975-2006, Featuring Colorectal Cancer Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates
Brenda K. Edwards et al.
CANCER (2010)
Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer
X. Gao et al.
ONCOGENE (2010)
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials
Daniel Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Biologically active sphingolipids in cancer pathogenesis and treatment
B Ogretmen et al.
NATURE REVIEWS CANCER (2004)
Share Paper
